Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)
Compose a Response to This Article
Other responses
No responses have been published for this article.